News | Stroke | April 05, 2018

Brainomix Secures $9.8m Investment to Tackle Strokes With AI

Software employs artificial intelligence with the ASPECTS method to enable faster stroke diagnosis and treatment

April 5, 2018 — Medical imaging company Brainomix has attracted £7m ($9.8 million) of investment to bring its artificial intelligence (AI) software for fast stroke diagnosis and treatment to the global healthcare market.

Boehringer Ingelheim Venture Fund (BIVF), the corporate venture fund of the global pharmaceutical company Boehringer Ingelheim, joined the round, which was led by university investment veterans Parkwalk Advisors. Existing investors Chimera Partners and Oxford University Innovation Fund also participated.

Brainomix's flagship software solution, e-ASPECTS, uses AI to provide a fast and standardized assessment of stroke patient computed tomography (CT) scans, supporting quick and consistent treatment decisions by medical professionals, irrespective of their experience and expertise. The software works by automating the clinically validated Alberta Stroke Program Early CT Score (ASPECTS) method. e-ASPECTS provides physicians with a clinical support tool that is designed to improve stroke treatment outcomes at much lower overall cost.

The injection of cash will allow Brainomix to further commercialize its intelligent medical imaging and workflow software solutions and expand its market penetration around the world.

For more information: www.brainomix.com

Related Content

Sponsored Content | Videos | Enterprise Imaging | February 19, 2020

itnTV "Conversations": Expanding Server-side Technology Across the Enterprise

Bill Lacy, vice president, Medical Informatics at FUJIFILM Medic...

Novel Coronavirus 2019-nCoV Pneumonia. #coronavirus #nCoV2019 #2019nCoV #COVID19

Image by _freakwave_ from Pixabay

News | Computed Tomography (CT) | February 16, 2020

FDA Statement on Actions in Response to 2019 Novel Coronavirus

February 16, 2020 — The following statement was issued by the U.S.

negative RT-PCR results and chest CT findings compatible with 2019-nCoV pneumonia. #coronavirus #nCoV2019 #2019nCoV #COVID19

Figure 1: Patient flowchart. Of 167 patients screened, 5 (3%) had negative RT-PCR results and chest CT findings compatible with 2019-nCoV pneumonia. Chart courtesy of Radiology

Feature | Computed Tomography (CT) | February 14, 2020

How Radiologists are Analyzing the 2019-nCoV Coronavirus Pneumonia Epidemic

As the 2019-nCoV Pneumonia is taking the world by storm, researchers have found a possible way to predict this virus

The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

News | Artificial Intelligence | February 13, 2020

FDA Clears Artificial Intelligence to Guide User for Optimal Cardiac Ultrasound Imaging

February 13, 2020 — The U.S.

Mobile devices proved both reliable and accurate for the clinical decision to administer IV thrombolysis in patients with acute stroke

Appearance of same unenhanced CT scan on three reading systems: E-2620 monitor (Barco) (A), Galaxy S8 Plus (Samsung) smartphone (B) and ThinkPad T460s laptop computer (Lenovo) (C).

News | Computed Tomography (CT) | February 12, 2020

Smartphone, Laptop Prove Reliable and Accurate for Acute Stroke Decision

February 12, 2020 — Mobile devices proved both reliable and accurate for the clinical decision to administer IV throm

Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive Intelligence solution. Ethos therapy is an artificial intelligence (AI)-driven holistic solution that provides an opportunity to transform cancer care.

News | Image Guided Radiation Therapy (IGRT) | February 11, 2020

Varian Receives FDA 510(k) Clearance for Ethos Therapy

February 11, 2020 — Varian announced it has received FDA 510(k) c

CT image of Novel Coronavirus 2019-nCoV from the Radiology article showing a baseline CT image of a 75 year old male with multiple patchy areas of pure ground glass opacity (GGO) and GGO with reticular and/or interlobular septal thickening. Follow-up CT images on day 3 after admission show an overlap of organizing pneumonia with diffuse alveolar damage in that it is more diffuse and associated with underlying reticulation. Read more and see 15 more images from novel coronavirus patients in the article.

An image from the Radiology article showing a baseline CT image of a 75 year old male with multiple patchy areas of pure ground glass opacity (GGO) and GGO with reticular and/or interlobular septal thickening. Follow-up CT images on day 3 after admission show an overlap of organizing pneumonia with diffuse alveolar damage in that it is more diffuse and associated with underlying reticulation. Read more and see 15 more images from novel coronavirus patients in the article.

Feature | Computed Tomography (CT) | February 11, 2020

Chest CT Findings of Patients Infected With Novel Coronavirus 2019-nCoV Pneumonia

February 11, 2020 — The Radiological Society of North America (RSNA) jo

Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast

Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast. A small mass with micro-calcifications on the right-side breast was detected correctly by AI with an abnormality score of 96%. This case was recalled by 7 out of 14 radiologists (4 breast radiologists and 3 general radiologists) initially (without AI) and all 14 radiologists recalled this case correctly with the assistance of AI.

News | Artificial Intelligence | February 11, 2020

AI-assisted Radiologists Can Detect More Breast Cancer with Reduced False-positive Recall

February 11, 2020 — A new study, published in...

PaxeraHealth enterprise imaging, PACS, VNA solutions

News | Enterprise Imaging | February 11, 2020

PaxeraHealth Awarded a Supplier Agreement with Vizient

February 11, 2020 — Enterprise Imaging developer PaxeraHealth

A patient-specific airway stents developed by Cleveland Clinic physician Tom Gildea, M.D.

A patient-specific airway stents developed by Cleveland Clinic physician Tom Gildea, M.D.

News | Computed Tomography (CT) | February 10, 2020

FDA Approves 3D-printed Airway Stents Developed by Cleveland Clinic Doctor

February 10, 2020 — The U.S.